Delivery Order SPE2DB22D9316-SPE2DB24FYP45
Award Date
6/13/24
Potential Completion Date
7/8/24
Potential Value
$40K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $80,218.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order for the supply of Keytruda 100 mg/4 ml vial 4 ml, a specialized oncology medication, to support the recurring medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the delivery of Keytruda 100 mg/4 ml vials. The $40,109.20 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products to support the recurring medical supply needs of Department of Defense...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Keytruda 100 mg/4 ml vials. The $48,171.42 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on August 8, 2024, with a completion date of August 29, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $16,043.68 firm fixed-price delivery order is for the pharmaceutical product Keytruda, a cancer treatment medication, and has an ultimate completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Keytruda 100 mg/4 ml vial 4 ml to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with a ceiling value of $32,114.28 and an ultimate completion date of September 19, 2024. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $40,142.85, is for the delivery of Keytruda 100 mg/4 ml vials to support the recurring medical supply needs of military health facilities. The contract has a completion date of June 25, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The IDC allows the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The specific delivery order...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) for the delivery of Keytruda 100 mg/4 ml vial 4 ml. The $77,505.20 firm-fixed-price delivery order contract has a completion date of January 31, 2023. DMS Pharmaceutical Group is a key pharmaceutical supplier to the U.S. Department of Defense, having secured a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of Keytruda 100 mg/4 ml vial, a cancer medication, to the Defense Logistics Agency (DLA). The $32,114.28 firm fixed-price delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a wide range of...
This firm fixed-price federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of the oncology drug Keytruda 100mg/4ml to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The $40,109.20 contract has a period of performance through September 27, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that provides a wide range of medications and medical supplies to support the Department of Defense...